News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RAMMF market cap is 6.57M. The company's latest EPS is CAD -0.0647 and P/E is -0.77.
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 5.61M | 5.48M | 4.38M | 3.9M | 5.07M |
| Operating Income | -5.53M | -7.56M | -7.18M | -18.24M | -8.14M |
| Net Income | -6.82M | -7.43M | -7.11M | -20.96M | -7.72M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 42.69M | 37.17M | 59.71M | 39.31M | 32.3M |
| Total Liabilities | 4.56M | 1.34M | 3.32M | 3.72M | 2.84M |
| Total Equity | 38.13M | 35.84M | 56.39M | 35.59M | 29.47M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.81M | -2.92M | -3.82M | -5.91M | -4.39M |
| Investing | -273k | -1.56M | -6.83M | -1.15M | 128k |
| Financing | 36.42M | -2.91M | -191k | -354k | -410k |
| Market Cap | 6.57M |
| Price to Earnings Ratio | -0.77 |
| Price to Sales Ratio | 1.18 |
| Price to Cash Ratio | 1.17 |
| Price to Book Ratio | 0.2 |
| Dividend Yield | - |
| Shares Outstanding | 119.39M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | RAMM Pharma Corporation (PK) |
| Address |
82 richmond st toronto, ontario M5C 1P1 |
| Website | https://www.rammpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
